NCT03685331 · Interventional trial
HOPE: Olaparib, Palbociclib and Fulvestrant in Patients With BRCA Mutation-associated, HR+, HER2-metastatic Breast Cancer
Overall registry status Completed
Phase 1
Conditions Advanced Breast Cancer, BRCA1 Mutation, BRCA2 Mutation, Locally Advanced Breast Cancer, Metastatic Breast Cancer
Delaware Valley sites
- Abramson Cancer Center of the University of Pennsylvania · Philadelphia, PA · Philadelphia County
First posted
Registry updated
Added to the directory